Marksans Pharma Limited — Guaifenesin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Guaifenesin · $576.5K export value · DGFT Verified
Marksans Pharma Limited is the #9 Indian exporter of Guaifenesin with $576.5K in export value and 28 verified shipments. Marksans Pharma Limited holds a 2.2% market share in Guaifenesin exports across 3 countries. The company exports 22 pharmaceutical products worth $125.0M across 11 therapeutic categories.
Marksans Pharma Limited — Guaifenesin Export Profile: Buyers & Destinations
Where Does Marksans Pharma Limited Export Guaifenesin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $407.7K | 19 | 73.4% |
| IRAQ | $131.5K | 8 | 23.7% |
| TURKEY | $16.1K | 1 | 2.9% |
Marksans Pharma Limited exports Guaifenesin to 3 countries. The largest destination is UNITED STATES accounting for 73.4% of Marksans Pharma Limited's Guaifenesin shipments, followed by IRAQ (23.7%) and TURKEY (2.9%). These destinations reflect Marksans Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Guaifenesin from Marksans Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TIME-CAP LABS, | UNITED STATES | $322.5K | 12 |
| ORGANO COMPANY LTD.FOR PHARMACEUTIC | IRAQ | $103.8K | 6 |
| TIME CAP LABS | UNITED STATES | $62.0K | 4 |
| ORGANO COMPANY FOR TRADING PHARMACE | IRAQ | $43.8K | 3 |
| TIME-CAP LABS, INC | UNITED STATES | $23.0K | 2 |
| TIME-CAP LABS INC | UNITED STATES | $92 | 1 |
Marksans Pharma Limited supplies Guaifenesin to 6 buyers globally. The largest buyer is TIME-CAP LABS, (UNITED STATES), followed by ORGANO COMPANY LTD.FOR PHARMACEUTIC (IRAQ) and TIME CAP LABS (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Guaifenesin Export Value and How Much Does Marksans Pharma Limited Contribute?
India exported $19.9M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. Marksans Pharma Limited contributes $576.5K to this total, accounting for 2.2% of India's Guaifenesin exports. Marksans Pharma Limited ships Guaifenesin to 3 countries through 6 buyers.
What Is the Average Shipment Value for Marksans Pharma Limited's Guaifenesin Exports?
Marksans Pharma Limited's average Guaifenesin shipment value is $20.6K per consignment, based on 28 shipments totaling $576.5K. The largest destination is UNITED STATES (73.4% of Marksans Pharma Limited's Guaifenesin exports).
How Does Marksans Pharma Limited Compare to Other Indian Guaifenesin Exporters?
Marksans Pharma Limited ranks #9 among 151 Indian Guaifenesin exporters with a 2.2% market share. The top 3 exporters are GRANULES INDIA LIMITED ($9.1M), ELYSIUM PHARMACEUTICALS LTD ($3.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($899.7K). Marksans Pharma Limited processed 28 shipments to 3 destination countries.
What Guaifenesin Formulations Does Marksans Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Doloflu (Paracetamol 500mg - Guaifenesin | $103.8K | 6 |
| PHARMACEUTICAL PRODUCTS -GUAIFENESIN EXTENDED-RELEASE TAB 1200 MG Batch No: 140917,140918,140919 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS - GUAIFENESIN EXTENDED-RELEASE TAB 600 MG Batch No: 140916,140896,140897 | $48.4K | 1 |
| PHARMACEUTICAL PRODUCTS- GUAIFENESIN EXTENDED-RELEASE TAB 1200 MG Batch No: 150323,150283 | $27.3K | 1 |
| PHARMACEUTICAL PRODUCTS - GUAIFENESIN EXTENDED-RELEASE TAB 600 MG Batch No: 150325 | $26.5K | 1 |
| PHARMACEUTICAL PRODUCTS -GUAIFENESIN EXTENDED-RELEASE TAB 600 MG Batch No: 150326 | $26.3K | 1 |
| PHARMACEUTICAL PRODUCTS - GUAIFENESIN EXTENDED-RELEASE TAB 1200 MG Batch No: 150324 | $25.4K | 1 |
| PHARMACEUTICAL PRODUCTS -GUAIFENESIN EXTENDED-RELEASE TAB 600 MG Batch No: 142244 | $25.4K | 1 |
| PHARMACEUTICAL PRODUCTS GUAIFENESIN EXTENDED RELEASE TAB 600 MG Batch No 150894 | $25.2K | 1 |
| PHARMACEUTICAL PRODUCTS - GUAIFENESIN EXTENDED-RELEASE TAB 600 MG Batch No: 142245 | $23.7K | 1 |
Marksans Pharma Limited exports 22 distinct Guaifenesin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Doloflu (Paracetamol 500mg - Guaifenesin with 6 shipments worth $103.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Guaifenesin to Key Markets
What Marksans Pharma Limited must comply with to export Guaifenesin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Marksans Pharma Limited Compare to Nearest Guaifenesin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | EMCURE PHARMACEUTICALS LIMITED | $645.9K | 46 | 11 | $14.0K |
| 8 | GLENMARK PHARMACEUTICALS LIMITED | $594.8K | 30 | 7 | $19.8K |
| 9 | MARKSANS PHARMA LIMITED ★ | $576.5K | 28 | 3 | $20.6K |
| 10 | DR.REDDY'S LABORATORIES LTD | $572.2K | 33 | 1 | $17.3K |
| 11 | ELYSIUM PHARMACEUTICALS LIMITED | $566.3K | 14 | 1 | $40.5K |
Marksans Pharma Limited ranks #9 among 151 Indian Guaifenesin exporters. Average shipment value of $20.6K compared to the market average of $131.8K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and GLENMARK PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Guaifenesin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 118 | 11.2% |
| NHAVA SHEVA SEA (INNSA1) | 94 | 9.0% |
| JNPT | 74 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 70 | 6.7% |
| HYDERABAD AIR | 53 | 5.0% |
| HYDERABAD ICD (INSNF6) | 50 | 4.8% |
| MUNDRA SEA (INMUN1) | 50 | 4.8% |
| MUNDRA SEA | 47 | 4.5% |
Geopolitical & Trade Policy Impact on Marksans Pharma Limited's Guaifenesin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Marksans Pharma. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, a crucial maritime route for trade between Asia and Europe. Major shipping lines have introduced an 'Emergency Risk Surcharge' ranging from $250 to $500 per TEU for cargo transiting the Bab-el-Mandeb Strait, effective February 2025. This surcharge elevates shipping costs, potentially impacting the competitiveness of Indian pharmaceutical exports to European and US East Coast markets. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded in January 2026, offers a silver lining. The FTA eliminates tariffs on Indian pharmaceuticals, APIs, vaccines, and medical devices, providing immediate cost relief and enhancing market access for Indian exporters. This development positions Marksans Pharma favorably to increase its footprint in the European market, leveraging its existing regulatory approvals and manufacturing capabilities. (en.wikipedia.org)
Marksans Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. Marksans Pharma has demonstrated a strong commitment to regulatory compliance. In November 2025, the company's Goa facility underwent a current Good Manufacturing Practice (cGMP) inspection by the US FDA, concluding with zero Form 483 observations. This outcome reflects Marksans' dedication to adhering to international quality standards and regulatory requirements. (capitalmarket.com)
Furthermore, the company's subsidiaries have achieved significant regulatory milestones. Time-Cap Laboratories Inc., Marksans' US subsidiary, received an Establishment Inspection Report (EIR) from the US FDA for its New York-based facility in June 2025, following an inspection that resulted in only one observation with no data integrity issues. Such achievements bolster Marksans' reputation as a reliable and compliant pharmaceutical manufacturer. (business-standard.com)
About Marksans Pharma Limited
Marksans Pharma Limited exports 22 products worth $125.0M. Beyond Guaifenesin, top products include Ibuprofen, Amino, Gabapentin, Acetaminophen, Loratadine. View the complete Marksans Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Marksans Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 28 individual customs records matching Marksans Pharma Limited exporting Guaifenesin, covering 22 formulations to 3 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Guaifenesin Export Data from Marksans Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Marksans Pharma Limited's Guaifenesin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Marksans Pharma Limited
Full Company Profile →
22 products · $125.0M total trade · 11 categories
Guaifenesin Stats
Company Overview
Top Products by Marksans Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Marksans Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current shipment-level data, contact TransData Nexus.